Julien Blouin

Stock Analyst at Goldman Sachs

(1.88)
# 3,160
Out of 5,172 analysts
28
Total ratings
52.38%
Success rate
-1.08%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $34.11
Upside: +9.94%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $17.05
Upside: -0.29%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $293.80
Upside: +38.53%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $97.36
Upside: +8.87%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $27.38
Upside: +35.14%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $11.84
Upside: +68.92%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $28.25
Upside: +11.50%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $24.39
Upside: +76.30%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $14.26
Upside: +19.21%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $100.28
Upside: +44.60%
Initiates: Buy
Price Target: $176
Current: $131.99
Upside: +33.34%
Initiates: Neutral
Price Target: $318
Current: $240.19
Upside: +32.40%
Initiates: Neutral
Price Target: $81
Current: $57.98
Upside: +39.70%
Initiates: Buy
Price Target: $187
Current: $121.79
Upside: +53.54%